drugset / Trial / NCT00009841
Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
Treatment
Summary
RATIONALE: Gene therapy may kill cancer cells by inhibiting a gene that promotes the development and growth of cancer. PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who have advanced head and neck cancer.
Timeline
- Start
- 1999-03
- Primary completion
- 2002-03
- Completion
- 2002-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EGFR Antisense DNA | Antisense oligonucleotide | — | Other |
| Background | DC-cholesterol liposome | Unknown | — | Other |